Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease

By sjmartinez • December 15, 2024

Mahurkar-Joshi S, Thompson M, Villarruel E, Lewis JD, Lin LD, Farid M, Nayeb-Hashemi H, Storage T, Weiss GA, Limketkai BN, Sauk JS, Mayer EA, Chang L. Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease. Neurogastroenterol Motil. 2024 Dec 13:e14980. doi: 10.1111/nmo.14980. Epub ahead of print. PMID: 39673136.

Tags: Celiac Disease, Digestive Diseases, DNA Methylation‐Based Biomarkers, inflammatory bowel disease, Irritable Bowel Syndrome, machine learning, Publications

From embedded interprofessional clinics to expanded alcohol-associated liver disease programs

Winder GS, Arab JP, Goswami Banerjee A, Bryce K, Fipps DC, Hussain F, Im G, Omary L, Patel AA, Patel S, Rubman S, Serper M,[...]

Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials

Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, McGovern D, Chan E, Smith MI, Ungaro F, Rieder F, Aden K, Shackelton[...]

Worsening Racial and Ethnic Disparities in Colorectal Cancer Screening Rates in United States Federally Qualified Health Centers

Zhao MY, Aaronson MRM, Singh V, De Silva SR, Badiee J, May FP. Worsening Racial and Ethnic Disparities in Colorectal Cancer Screening Rates in United[...]